Significantly, with the high-throughput sequencing technologies development, mutations of spliceosome components especially SR proteins have been identified as a novel class of driver mutations in a variety of human diseases, such as cancer and myelodysplastic syndromes (MDS) (Jenkins and Kielkopf, 2017). The gene discussed is RNPS1; the disease is cancer.